Αποτελέσματα Αναζήτησης
30 Αυγ 2024 · ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Atrial Fibrillation. They should be essential in everyday clinical decision making.
30 Νοε 2023 · In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
30 Αυγ 2024 · Tables 3 and 4 below outline new recommendations and those with important revisions. These initiatives have been designed to make the 2024 ESC Guidelines for the management of AF easier to read, follow, and implement, with the aim of improving the lives of patients with AF.
The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart
13 Δεκ 2011 · This review discusses the relative risks and benefits of rate versus rhythm control strategies, describes the targets and available methods for rate control, and highlights special considerations for ventricular rate control when cardiac resynchronization therapy (CRT) is used in patients with AF.
Recommended Therapies for Heart Rate and Rhythm Control in Patients with Atrial Fibrillation. Whether a rate control or rhythm control strategy is chosen is very specific to each individual patient.
Early rhythm control: A heart rate control (resting heart rate <80 beats/min) strategy is reasonable for symptomatic management of AF (COR 2a). In patients with reduced LV function and persistent (or high burden) AF, a trial of rhythm control should be recommended to evaluate whether AF is contributing to the reduced LV function (COR 1).
